by SD-AbarceoPharma | Mar 29, 2026 | Diabetes, Events, News & Press releases
23 March Abarceo attended RESI Premier Financing Event to meet investors and partners, interested in changing the diabetes therapeutics field. Abarceo presented it’s aim to release the first oral treatment for Type 1 Diabetes and the first drug providing...
by SD-AbarceoPharma | May 23, 2025 | Diabetes, News & Press releases, VDAC1
We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
Recent Comments